Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy
Immune checkpoint therapies (ICT) have transformed the treatment of cancer over the past decade. However, many patients do not respond or suffer relapses. Successful immunotherapy requires epitope spreading, but the slow or inefficient induction of functional antitumoral immunity delays the benefit...
Main Authors: | Guillaume Kellermann, Nicolas Leulliot, Julien Cherfils-Vicini, Magali Blaud, Patrick Brest |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1382236/full |
Similar Items
-
Humoral Epitope Spreading in Autoimmune Bullous Diseases
by: Dario Didona, et al.
Published: (2018-04-01) -
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading
by: Elvira Favoino, et al.
Published: (2019-04-01) -
Multiple autoimmunity and epitope spreading in monozygotic twins
by: Esperanza Avalos-Díaz, et al.
Published: (2021-01-01) -
Function and potentials of M. tuberculosis epitopes
by: Juraj eIvanyi
Published: (2014-03-01) -
ATM-TCR: TCR-Epitope Binding Affinity Prediction Using a Multi-Head Self-Attention Model
by: Michael Cai, et al.
Published: (2022-07-01)